{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:18:29Z","timestamp":1790129909038,"version":"4.0.1"},"reference-count":16,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,12,11]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Anti-CD30 therapy for Hodgkin lymphoma led to transient loss of detectable CD4+ T-cell HIV RNA and a decrease in residual plasma viremia. Targeting nonviral markers expressed on HIV-1 transcriptionally active cells may lead to reduced measures of HIV-1 persistence.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018024364","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T21:45:15Z","timestamp":1544219115000},"page":"3479-3482","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":15,"title":["Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma"],"prefix":"10.1182","volume":"2","author":[{"given":"Chia-Ching","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Thanh","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica A.","family":"Gibson","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Ball-Burack","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise E.","family":"Hogan","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Descours","sequence":"additional","affiliation":[{"name":"Molecular Virology Unit, Human Genetic Institute, Centre National de la Recherche Scientifique, Montpellier, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander B.","family":"Carvidi","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadie","family":"Munter","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Bakkour","sequence":"additional","affiliation":[{"name":"Blood Systems Research Institute, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Busch","sequence":"additional","affiliation":[{"name":"Blood Systems Research Institute, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Milush","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Deeks","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Henrich","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,12,7]]},"reference":[{"issue":"8","key":"2020021108294061100_B1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nm.4108","article-title":"International AIDS Society global scientific strategy: towards an HIV cure 2016","volume":"22","author":"Deeks","year":"2016","journal-title":"Nat Med"},{"issue":"2","key":"2020021108294061100_B2","doi-asserted-by":"crossref","first-page":"e1006856","DOI":"10.1371\/journal.ppat.1006856","article-title":"Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30","volume":"14","author":"Hogan","year":"2018","journal-title":"PLoS Pathog"},{"issue":"5","key":"2020021108294061100_B3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/COH.0000000000000482","article-title":"Markers of the HIV-1 reservoir: facts and controversies","volume":"13","author":"Bruel","year":"2018","journal-title":"Curr Opin HIV AIDS"},{"issue":"6","key":"2020021108294061100_B4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00002030-199406000-00003","article-title":"High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS","volume":"8","author":"Pizzolo","year":"1994","journal-title":"AIDS"},{"issue":"13","key":"2020021108294061100_B5","doi-asserted-by":"crossref","first-page":"F45","DOI":"10.1097\/00002030-199611000-00001","article-title":"Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome","volume":"10","author":"Rizzardi","year":"1996","journal-title":"AIDS"},{"issue":"2","key":"2020021108294061100_B6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2249.1997.d01-1005.x","article-title":"High serum level of soluble CD30 in acute primary HIV-1 infection","volume":"108","author":"Pizzolo","year":"1997","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"2020021108294061100_B7","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1073\/pnas.94.4.1390","article-title":"CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2","volume":"94","author":"Tsitsikov","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2020021108294061100_B8","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/jmv.20733","article-title":"Significant link between sCD30 changes and HIV viremia in patients treated with HAART","volume":"78","author":"Biswas","year":"2006","journal-title":"J Med Virol"},{"issue":"7","key":"2020021108294061100_B9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/0092-8674(93)90361-S","article-title":"CD30 antigen, a marker for Hodgkin\u2019s lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF","volume":"73","author":"Smith","year":"1993","journal-title":"Cell"},{"issue":"2","key":"2020021108294061100_B10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/clim.1998.4636","article-title":"CD30 in normal and neoplastic cells","volume":"90","author":"Chiarle","year":"1999","journal-title":"Clin Immunol"},{"issue":"7","key":"2020021108294061100_B11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nbt.2289","article-title":"The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma","volume":"30","author":"Senter","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"8","key":"2020021108294061100_B12","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1128\/JCM.00425-17","article-title":"Evaluation of the Aptima HIV-1 Quant Dx assay for HIV-1 RNA quantitation in different biological specimen types","volume":"55","author":"Yek","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2020021108294061100_B13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcv.2016.02.002","article-title":"Aptima HIV-1 Quant Dx--a fully automated assay for both diagnosis and quantification of HIV-1","volume":"77","author":"Nair","year":"2016","journal-title":"J Clin Virol"},{"issue":"15","key":"2020021108294061100_B14","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1097\/QAD.0000000000001937","article-title":"Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1","volume":"32","author":"Chang","year":"2018","journal-title":"AIDS"},{"issue":"6","key":"2020021108294061100_B15","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1158\/1535-7163.MCT-15-0036","article-title":"CD30 downregulation, MMAE resistance, and MDR1 upregulation are all associated with resistance to brentuximab vedotin","volume":"14","author":"Chen","year":"2015","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"2020021108294061100_B16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.chom.2017.12.004","article-title":"Getting the \u201ckill\u201d into \u201cshock and kill\u201d: strategies to eliminate latent HIV","volume":"23","author":"Kim","year":"2018","journal-title":"Cell Host Microbe"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/23\/3479\/1630016\/advances024364.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/23\/3479\/1630016\/advances024364.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T13:50:55Z","timestamp":1581429055000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/23\/3479\/16132\/Transient-loss-of-detectable-HIV1-RNA-following"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,7]]},"references-count":16,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2018,12,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018024364","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,7]]}}}